PhD, Institute of Microbiology, National Academy of Science of Armenia, Yerevan, Armenia, Biology/Immunology & Microbiology
MS, Yerevan State University, Yerevan, Armenia, Biophysics/Immunology & Microbiology
BS, Yerevan State University, Yerevan, Armenia, Biophysics
Postdoctoral Fellowship, Department of Pediatrics, Hematology/Oncology, RushUniversity Medical Center, Chicago, IL, Institute of Experimental Biology, National, Academy of Science of Armenia, Yerevan, Armenia
Postgraduate Training, Gamalei Institute of Epidemiology and Microbiology, National Academy of Medical Science, Moscow, Russia, Institute of Molecular Biology, National Academy of Science of Armenia, Yerevan, Armenia
Basic and translational research of blood-induced joint disease and joint hemostasis in patients with hemophilia. Areas of current interest include the development of diagnostic/prognostic biomarkers and therapeutic targets for hemophilic arthropathy and understanding of the molecular mechanisms underlying the disease process.
Hakobyan N, Valentino LA, Cong L, Enockson C, Song X, Desai S, Radtke R, Fogg LF. Hemarthrosis model in mice: BSS–bleeding severity score assessment system. Haemophilia 2016; in press.
Valentino LA, Cong L, Enockson C, Song X, Scheiflinger F, Muchitsch EM, Turecek PL, Hakobyan N. The Biological Efficacy Profile of BAX 855, a PEGylated Recombinant Factor VIII Molecule. Haemophilia. Haemophilia. 2015; 21(1):58-63.
Valentino LA, Hakobyan N, Enockson C, Simpson ML, Kakodkar NC, Cong L and Song X. Importance of first joint haemorrhage as the trigger of synovitis and arthropathy: Experimental studies. Haemophilia 2012; 18(3):310-8.
Hakobyan N, Enockson C, Cole A, Sumner DR, Valentino LA. Experimental haemophilic arthropathy in a mouse model of a massive hemarthrosis: Gross, radiological, and histological changes. Haemophilia 2008; 14: 804-809. Sun J,
Hakobyan N, Valentino, LA, Feldman BL, Samulski RJ, Monahan PE. Intra-articular factor IX protein or gene replacement protects against development of hemophilic synovitis in the absence of circulating factor IX. Blood 2008; 112(12): 4532-41.
2016-2018 Principal Investigator. Baxalta US Inc
2015-2016 Principal Investigator. OPKO Biologics Ltd.
2014-2016 Co-Principal Investigator. Baxter Healthcare Corporation